Convatec Group PLC (CTEC.L)
Convatec is a British medical products company that helps people manage chronic conditions like wounds, ostomies, and bladder issues.
Is Convatec Group PLC a good stock for a UK beginner?
The honest version: There's no rating here and nothing for sale. In its favour: Essential products that people need regardless of the economy. Worth weighing: Recent drop in earnings growth. Below, we lay out what it does, what its numbers mean, and the honest risks, so you can decide for yourself.
Over about 2 years to 2026-07-31. This is the share price only - reinvesting the dividends would add to it. Past performance is not a guide to the future, and it could just as easily have fallen.
How much has Convatec Group PLC actually fallen?
Over the last 2 years of daily prices, Convatec Group PLC fell as much as −34% from a high to a later low. Drops of this size are a normal part of owning a share - worth knowing in advance, so a dip doesn't come as a shock.
Worst peak-to-trough fall in the daily closing price over the period we hold. Past falls are not a forecast - it can fall further, or recover.
Based on beta - how much the price swings versus the whole market. Bumpier isn't bad; it just means a rougher ride, which matters more the sooner you might need the money.
Prices move on results, news and the mood of the whole market - no single headline explains a day, and a quiet week is usually just noise, not a signal.
Aging global population drives sustained demand for chronic care.
Significant loss of patent protection or pricing power.
What does Convatec Group PLC do?
Convatec makes the essential medical supplies that patients use every day to manage long-term health conditions, such as bandages for complex wounds or equipment for those living with an ostomy. Sales to hospitals, and directly to patients through healthcare providers, bring in the money. Look at whether they can grow sales while reining in manufacturing costs, having invested heavily in new technology to boost their efficiency.
On our factor screen it looks strongest on quality and value, and weakest on growth.
- ✓Pays a dividend - about 2.4% a year
- ✓Growing - revenue up about 7% over the year
- !High P/E of 37 - big growth is already priced in
- Essential products that people need regardless of the economy
- Strong gross margins showing efficient production
- Lower volatility compared to the broader market
- Pressure from healthcare providers to lower prices
- Rising costs of raw materials and logistics
- Regulatory hurdles for new medical devices
What do Convatec Group PLC's numbers mean?
Does Convatec Group PLC pay a dividend?
Yes - Convatec Group PLC currently pays a dividend of about 2.4% a year (the yearly payout as a share of the price). A dividend is a slice of profit handed to shareholders; the yield moves as the price moves, and a company can cut or stop it.
What do the numbers say about Convatec Group PLC's dividend?
There's no rating here, and we don't judge whether the dividend will continue - that would be advice. Here are the figures income investors usually look at, and what each one means, so you can weigh it up yourself.
Figures are from the latest available data and can be distorted by one-off results. Past payments don't predict future ones, and a dividend can be cut at any time. This lays out the numbers to help you understand them - it is not a view on what will happen.
When does Convatec Group PLC report earnings, and how did recent quarters go?
Convatec Group PLC is next scheduled to report on about 2026-08-04 - dates can move, and we don't predict results; this just tells you when to look.
Each quarter a company reports its results against what analysts expected. ‘Beating’ or ‘missing’ is about that expectation, not whether the business is doing well in absolute terms.
See who else reports over the next two weeks →
Reported vs expected earnings per share (EPS) from published results; the expectation is the analyst consensus, not our view. Report dates are estimates that can move.
More in Healthcare
Eli Lilly
West Pharmaceutical Services, Inc.
Incyte Corporation
The Cigna Group
Zimmer Biomet Holdings, Inc.
Moderna, Inc.
Gilead Sciences, Inc.
Regeneron Pharmaceuticals, Inc.What are the scenarios for Convatec Group PLC?
An illustrative range for the year ahead, with the assumption behind each case — not a prediction or a price target.
What are the pros and cons of Convatec Group PLC?
How many points the write-up makes each way — a balance check, not a score or verdict.
- Essential products that people need regardless of the economy
- Strong gross margins showing efficient production
- Lower volatility compared to the broader market
- Recent drop in earnings growth
- High current price relative to recent profits
- Relatively low net profit margin
- Pressure from healthcare providers to lower prices
- Rising costs of raw materials and logistics
- Regulatory hurdles for new medical devices
The write-up's own warning lights — if these start happening, the case above changes.
- A sustained turnaround in net profit growth
- A major acquisition that changes the company's scale
Built from public filings & market prices, checked for an education-only tone, and never a price target. How we make these →
This plain-English summary was auto-generated on 2026-08-02 from public data and checked for an education-only, no-advice tone (the figures above carry their own, usually fresher, 'as of' date). It's information, never a recommendation.